BioCentury
ARTICLE | Clinical News

Inovio preclinical data

November 23, 2009 8:00 AM UTC

Inovio Biomedical Corp. (NYSE-A:INO), San Diego, Calif. Product: SynCon H1N1 influenza DNA vaccine Indication: Vaccinate against H1N1 influenza virus Inovio's SynCon H1N1 and SynCon universal (H1N1, ...